Health Catalyst downgraded by Citigroup
$HCAT
Computer Software: Programming Data Processing
Technology
Citigroup downgraded Health Catalyst from Buy to Neutral
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/27/2025 | $4.00 | Overweight → Neutral | Piper Sandler |
| 8/11/2025 | Buy → Neutral | Citigroup | |
| 8/8/2025 | $4.00 | Overweight → Neutral | Cantor Fitzgerald |
| 6/17/2025 | Buy → Neutral | BTIG Research | |
| 4/9/2025 | Outperform → In-line | Evercore ISI | |
| 1/8/2025 | $9.00 | Sector Weight → Overweight | KeyBanc Capital Markets |
| 4/10/2024 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 1/3/2024 | $14.00 | Overweight | Barclays |
SCHEDULE 13D - Health Catalyst, Inc. (0001636422) (Subject)
8-K - Health Catalyst, Inc. (0001636422) (Filer)
SCHEDULE 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
3 - Health Catalyst, Inc. (0001636422) (Issuer)
4 - Health Catalyst, Inc. (0001636422) (Issuer)
SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of senior management will participate in the following upcoming investor conferences: The Stephens Annual Investment Conference, being held in Nashville, including a fireside chat with Ben Albert, President and Chief Operating Officer, Jason Alger, Chief Financial Officer, and Matt Hopper, SVP of Finance and Head of Investor Relations, on Wednesday, November 19, 2025 at 3:00pm CT.The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum,
SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle by Health Catalyst (Twistle), Lumeon by Health Catalyst (Lumeon), and Upfront by Health Catalyst (Upfront) have earned certified status by HITRUST for information security. HITRUST r2 Certification demonstrates that Twistle, Lumeon, and Upfront have met demanding regulatory compliance and industry-defined requirements that assess whether offerings are
Piper Sandler downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00
Citigroup downgraded Health Catalyst from Buy to Neutral
Cantor Fitzgerald downgraded Health Catalyst from Overweight to Neutral and set a new price target of $4.00
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G - Health Catalyst, Inc. (0001636422) (Subject)
SC 13G/A - Health Catalyst, Inc. (0001636422) (Subject)
SALT LAKE CITY, Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst", or the ", Company, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Matt Arens, CEO and Founder of First Light Asset Management, LLC ("First Light"), has been appointed to serve as a member of Health Catalyst's board of directors ("Board"), effective Dec. 1, 2025. A shareholder since Health Catalyst's IPO in 2019, First Light is the Company's largest shareholder, and First Light and Mr. Arens collectively o
Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins Healthmine as a seasoned leader with more than 25 years of experience in healthcare technology, transformation and analytics. He most recently served as Senior Vice President of Enterprise Transformation at VillageMD where he led the streamlining of clinical operations and scale value-based care delivery across the organization. Prio
Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement SALT LAKE CITY, Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ((", Health Catalyst, ", NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Ben Albert has been appointed as President and Chief Operating Officer. Albert served as the Chief Executive Officer & Co-Founder of Upfront Healthcare Services, Inc. until it was acquired by Health Catalyst in January, and has continued to ov
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. "For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these results beating our quarterly guidance on each measure," said Dan Burton, CEO of Health Catalyst. "By focusing on high-impact solutions with proven ROI and maintaining a commitment to understanding and evolving with our clients, we have reaffirmed our full-year
SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ((", Health Catalyst", , NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2025 operating results on Monday, November 10, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day. Conference Call Details The conference call can be accessed by dialing 800-343-5172 for U.S. participants, or 203-518-9856 for international participants, and referencing conference ID "HCATQ325." A live audio webcast will be available online at https://ir.healthcatalyst.com/.
SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (("Health Catalyst, NASDAQ:HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2025. "For the second quarter of 2025, I am pleased by our strong financial results, including total revenue of $80.7 million and Adjusted EBITDA of $9.3 million, with these results beating our quarterly guidance on each metric." said Dan Burton, CEO of Health Catalyst. "I also want to share my plan to retire from the CEO role at Health Catalyst effective June 30, 2026. By then, I will have been leading Health Catalyst full-time